University of North Carolina - Chapel Hill Medical Center is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
University of North Carolina - Chapel Hill Medical Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma.
Sponsors: Sirtex Medical.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina - Chapel Hill Medical Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina - Chapel Hill Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma.
University of North Carolina - Chapel Hill Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.